Alvaro Daniel Pinto, MD

MD @URosario 🇨🇴 | Research Trainee in CVD @MayoClinic | RYE 16’-17’ @Rotary 🇫🇷 | Aspiring Internist

[Loyola Vascular Surg @LoyolaVascular]

Meet our PGY3, Dr. Paula Pinto Rodriguez!

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

@LoyolaVascular @BWainwright628 @paulapintoro @K_ChawlaMD @vamsi_potluri @BAulivolaMD @msoultmd @khalilqatoMD 👏🏼👏🏼👏🏼

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

@ChristyTapiaA Excellent job Chris, congrats! 👏🏼👏🏼

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Finally, I’m grateful to Dr. @NicolasSantoyoS and the residents at URosario. During my time as a medical student, their commitment to the IMIG helped create opportunities for students to become involved in academic medicine, an experience that continues to shape my own journey.

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Never too late to share some good news!

I’m excited to share that I’ll be participating in IDWeek 2026 in Washington, D.C., where I’ll be presenting our work on predictors of carbapenemase-producing Enterobacteriaceae in Colombia alongside Dr Valeria Cormane Alfaro. /1

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

I’m especially grateful to the resident team, particularly Dr. Maria Rey-Salamanca and Dr. Edgar Santiago Castro-Prieto, for inviting us to collaborate on this dataset and for their support in preparing the presentation. /2

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

I’m also grateful to @NicolasSantoyoS and the residents at @URosario. During my time as a medical student, their commitment to the IMIG helped create opportunities for students to become involved in academic medicine, an experience that has continued to shape my own journey.

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

I’m especially grateful to the resident team, particularly Dr. Maria Rey-Salamanca and Dr. Edgar Santiago Castro-Prieto, for inviting us to collaborate on this dataset and for their support in preparing the presentation. /2

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

post-transplant lymphoproliferative disorder among patients who have undergone solid organ transplantation. /2

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Grateful for all the experiences and amazing individuals who have helped me get here. Excited for what’s ahead in this next chapter! (2/2)

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Over the past month, I’ve had the privilege of settling into my new role as a Research Trainee @MayoClinic! It has been an amazing first few weeks diving into cardio-oncology research under the guidance of Dr. Hector Villarraga and working alongside such a dedicated team (1/2)

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

@LoyolaVascular @paulapintoro @BWainwright628 @khalilqatoMD Hard work pays off! Congrats Pau! 👏🏼 @paulapintoro

[Loyola Vascular Surg @LoyolaVascular]

Congratulations to our Department of Surgery Grand Rounds Award recipients!

Dr. Paula Pinto Rodriguez - Vascular Trainee of the Year
Dr. Khalil Qato - Vascular Attending of the Year
Dr. Brandon Wainwright - Junior Resident Teaching

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

@sacalle1 @MarkDSiegel1 @TradIMYale Congrats Santiago! 👏🏼

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Had a great time at #ACC26! Meaningful connections and insightful learning. More to come!

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

@LauraOrtegaav @MayoClinicCV Felicidades Laura! Excelente trabajo 👏🏼

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

With prior data indicating an association between opioid use and worse periprocedural and post-op outcomes, increased monitoring and alternative pain management strategies are necessary.

DOI: https://t.co/oiexKYRX8d

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Grateful for the opportunity to present the results of our systematic review assessing the prevalence of opioid prescriptions in patients with PAD undergoing revascularization #ACC26 @YaleVAMOS @KimGSmolderen @CarlosMenaYale.

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Patients with PAD experience varying degrees of ischemic pain, and treatment options are limited. Our systematic review highlights that about one-third of patients with PAD receive opioid prescriptions before revascularization, and 42.5% after.

[Alvaro Daniel Pinto, MD @alvaro_daniel26]

Excellent presentation of a Gerbode defect corrected percutaneously in a pediatric patient by Ana Lucía Madrid, MD from Universidad Javeriana - Bogotá and future pediatrician 👏🏼 #ACC26